National Health Investors, Inc. (NHI) — Analyst outlook / Analyst consensus target is. Based on 18 analyst ratings, the consensus is bullish — 5 Buy, 12 Hold, 1 Sell.
The consensus price target is $85.20 (low: $83.00, high: $88.00), representing a downside of 0.1% from the current price $85.32.
Analysts estimate Earnings Per Share (EPS) of $2.91 and revenue of $0.27B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $3.14 vs est $2.91 (beat +7.8%). 2025: actual $3.03 vs est $3.01 (beat +0.6%). Analyst accuracy: 96%.
NHI Stock — 12-Month Price Forecast
$85.20
▼ -0.14% Downside
Average Price Target
Based on 18 Wall Street analysts offering 12-month price targets for National Health Investors, Inc., the average price target is $85.20, with a high forecast of $88.00, and a low forecast of $83.00.
The average price target represents a -0.14% change from the last price of $85.32.
Highest Price Target
$88.00
Average Price Target
$85.20
Lowest Price Target
$83.00
NHI Analyst Ratings
Hold
Based on 18 analysts giving stock ratings to National Health Investors, Inc. in the past 3 months
EPS Estimates — NHI
96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $3.14
vs Est $2.91
▲ 7.2% off
2025
Actual $3.03
vs Est $3.01
▲ 0.6% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is declining.
Revenue Estimates — NHI
76%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.335B
vs Est $0.268B
▲ 20.1% off
2025
Actual $0.379B
vs Est $0.270B
▲ 28.8% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
